Research Article

miR-146a Attenuates Sepsis-Induced Myocardial Dysfunction by Suppressing IRAK1 and TRAF6 via Targeting ErbB4 Expression

Figure 7

Overexpression of miR-146a decreased the levels of inflammatory cytokines in LPS-treated cardiomyocytes. The use of siErbB4 significantly reversed the effect of miR-146a. Data were expressed as mean ± SEM. versus the control group; versus the LPS group; versus the LPS group; versus the LPS + miR group; versus the LPS + miR group.